Literature DB >> 28414093

Imbalance in leptin-adiponectin levels and leptin receptor expression as chief contributors to triple negative breast cancer progression in Northeast India.

Rizwana Sultana1, Amal Ch Kataki2, Bibhuti Bhusan Borthakur3, Tarun K Basumatary4, Sujoy Bose5.   

Abstract

BACKGROUND: Triple-Negative breast cancer (TNBC), accounts for a large percentage of breast cancer cases in India including Northeast India. TNBC has an unclear molecular aetiology and hence limited targeted therapies. Human breast is comprised of glandular, ductal, connective, and adipose tissues. Adipose tissue is composed of adipocytes. The adipocytes apart from being energy storage depots, are also active sources of adipocytokines and/or adipokines. The role of adipokines in breast cancer including TNBC has been sporadically documented. Two adipokines in particular, leptin and adiponectin, have come to be recognized for their influence on breast cancer risk and tumour biology. Therefore, the aim of this study was to understand the association of differential expression of critical adipokines and associated cellular mechanism in the susceptibility and severity of TNBC in northeast Indian population.
MATERIALS AND METHODS: We collected 68 TNBC and 63 controls cases and examined for serum leptin and adiponectin levels using enzyme linked immunosorbent assay (ELISA). Leptin Receptor (Ob-R) mRNA expression was determined by real-time polymerase chain reaction (RT-PCR) assay. Differential Ob-R mRNA expression and correlation with cancer stem cell (CSC) markers was evaluated, and correlated with severity.
RESULTS: The serum leptin levels were significantly associated with TNBC severity, while the adiponectin levels were comparative. The serum leptin levels correlated inversely with the adiponetin levels. Serum leptin levels were unaffected with difference in parity. The difference in leptin levels in pre and post menopausal cases were found to be statistically non-significant. Higher leptin levels were also found to be associated obesity, mortality and recurrence. Obesity was found to be a factor for TNBC pathogenesis and severity. Increased Ob-R mRNA expression was associated with TNBC, significantly with TNBC severity, and was significantly higher in obese patients with higher grade TNBC cases. The Ob-R gene mRNA expression was significantly higher in the obese TNBC cases showing recurrence or mortality. The higher Ob-R gene mRNA expression correlated significantly with higher serum leptin levels and lower serum adiponectin levels in TNBC cases. The Ob-R mRNA expression with associated with modulation of CSC oct4 and nanog.
CONCLUSIONS: In conclusion, the present study is first of its kind on TNBC from northeast India, indicates that adipocytokines does play a role in TNBC pathogenesis. Thus, the understanding of molecular mechanisms of both leptin and adiponectin and their interplay in TNBC offer the prospects for new therapeutic approaches targeting similar signalling pathways.
Copyright © 2017 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Adiponectin; Cancer stem cell; Leptin; Leptin receptor; Triple negative breast cancer

Mesh:

Substances:

Year:  2017        PMID: 28414093     DOI: 10.1016/j.gene.2017.04.021

Source DB:  PubMed          Journal:  Gene        ISSN: 0378-1119            Impact factor:   3.688


  16 in total

Review 1.  The Multifaceted Nature of Tumor Microenvironment in Breast Carcinomas.

Authors:  Laura Annaratone; Eliano Cascardi; Elena Vissio; Ivana Sarotto; Ewa Chmielik; Anna Sapino; Enrico Berrino; Caterina Marchiò
Journal:  Pathobiology       Date:  2020-04-23       Impact factor: 4.342

Review 2.  Linking obesity-induced leptin-signaling pathways to common endocrine-related cancers in women.

Authors:  Eunice Nyasani; Iqbal Munir; Mia Perez; Kimberly Payne; Salma Khan
Journal:  Endocrine       Date:  2018-09-14       Impact factor: 3.633

3.  Gene expression of adipokines and adipokine receptors in the tumor microenvironment: associations of lower expression with more aggressive breast tumor features.

Authors:  Adana A M Llanos; Song Yao; Amartya Singh; John B Aremu; Hossein Khiabanian; Yong Lin; Coral Omene; Angela R Omilian; Thaer Khoury; Chi-Chen Hong; Shridar Ganesan; David J Foran; Michael J Higgins; Christine B Ambrosone; Elisa V Bandera; Kitaw Demissie
Journal:  Breast Cancer Res Treat       Date:  2020-10-16       Impact factor: 4.872

4.  Novel functionalized nanoparticles for tumor-targeting co-delivery of doxorubicin and siRNA to enhance cancer therapy.

Authors:  Yu Xia; Tiantian Xu; Changbing Wang; Yinghua Li; Zhengfang Lin; Mingqi Zhao; Bing Zhu
Journal:  Int J Nanomedicine       Date:  2017-12-22

Review 5.  Leptin signaling axis specifically associates with clinical prognosis and is multifunctional in regulating cancer progression.

Authors:  Tsung-Chieh Lin; Kuan-Wei Huang; Chia-Wei Liu; Yu-Chan Chang; Wei-Ming Lin; Tse-Yen Yang; Michael Hsiao
Journal:  Oncotarget       Date:  2018-03-30

6.  Meta-Analysis of Prevalence of Triple-Negative Breast Cancer and Its Clinical Features at Incidence in Indian Patients With Breast Cancer.

Authors:  Apurv Kulkarni; Devaki A Kelkar; Nidhi Parikh; Lingadahalli S Shashidhara; Chaitanyanand B Koppiker; Madhura Kulkarni
Journal:  JCO Glob Oncol       Date:  2020-07

Review 7.  Cancer and comorbidity: The role of leptin in breast cancer and associated pathologies.

Authors:  Amitabha Ray
Journal:  World J Clin Cases       Date:  2018-10-26       Impact factor: 1.337

Review 8.  Adipocytes in Breast Cancer, the Thick and the Thin.

Authors:  Ilona Rybinska; Roberto Agresti; Anna Trapani; Elda Tagliabue; Tiziana Triulzi
Journal:  Cells       Date:  2020-02-27       Impact factor: 6.600

Review 9.  The Importance of Breast Adipose Tissue in Breast Cancer.

Authors:  Charu Kothari; Caroline Diorio; Francine Durocher
Journal:  Int J Mol Sci       Date:  2020-08-11       Impact factor: 5.923

10.  Evaluation of the Impact of Cisplatin on Variances in the Expression Pattern of Leptin-Related Genes in Endometrial Cancer Cells.

Authors:  Dariusz Dąbruś; Robert Kiełbasiński; Beniamin Oskar Grabarek; Dariusz Boroń
Journal:  Int J Mol Sci       Date:  2020-06-10       Impact factor: 5.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.